Peter Paul Rubens was among the most influential artists in 17th-century Europe. Despite a childhood marred by a scandal that landed his father in prison, Rubens rose to become not only a prominent court painter in the Spanish Netherlands but also a lauded diplomat who worked across Western Europe.
With countless biographies written about the artist and exhibitions of his work continuing into the present day, the legacy of this Flemish Baroque artist is hard to overstate.
In this episode, Getty curator Anne Woollett discusses the life of Rubens through 17th-century biographies by three authors: Giovanni Baglione, Joachim von Sandrart, and Roger de Piles.
Sir Peter Paul Rubens was a Flemish artist and diplomat. He is considered the most influential artist of Flemish Baroque tradition. Rubens’s highly charged compositions reference erudite aspects of classical and Christian history.
A selection of three essential articles read aloud from the latest issue of The Economist. This week, the chance to flatten the climate curve, when, why and how to lift coronavirus lockdowns (9:25) and the arrest of Africa’s most wanted man (17:25).
Monocle 24’s “The Stack” speaks to Marianne Julia Strauss on her new book “Do You Read Me?” on the best bookshops around the globe. Then, author Patrick McGinnis on his new release “Fear Of Missing Out”.
The first results from vaccine trials are in and they are encouraging, but scientists are still urging caution. We hear the lowdown on the types of vaccines being developed and what hope there is of rolling them out any time soon.
01:38 Trump vs the WHO
President Trump has given the WHO an ultimatum in a tweet, threatening to pull out of the organisation within 30 days unless unclear demands are met. We discuss what this means for the pandemic, the USA and the future of international health cooperation
12:06 Where are we with vaccines?
The first results from vaccine trials are in and they are encouraging, but scientists are still urging caution. We hear the lowdown on the types of vaccines being developed and what hope there is of rolling them out any time soon.
Our hosts pick out things that have made them smile in the last week, including hopeful antibody research, at-home sketch comedy and printable board games.
Interview with Dr. Nicole Lurie on rapid vaccine development, including new tools to facilitate vaccine testing and manufacturing and persistent challenges.
The need to rapidly develop a vaccine against SARS-CoV-2 comes at a time of explosion in basic scientific understanding, including in areas such as genomics and structural biology, that is supporting a new era in vaccine development. Over the past decade, the scientific community and the vaccine industry have been asked to respond urgently to epidemics of H1N1 influenza, Ebola, Zika, and now SARS-CoV-2. An H1N1 influenza vaccine was developed relatively rapidly, largely because influenza-vaccine technology was well developed and key regulators had previously decided that vaccines made using egg- and cell-based platforms could be licensed under the rules used for a strain change. Although a monovalent H1N1 vaccine was not available before the pandemic peaked in the Northern Hemisphere, it was available soon afterward as a stand-alone vaccine and was ultimately incorporated into commercially available seasonal influenza vaccines.
Nicole Lurie is a strategic advisor to the CEO of the Coalition for Epidemic Preparedness Innovations. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal.
Online News Editor David Grimm talks with producer Joel Goldberg about the unique challenges of reopening labs amid the coronavirus pandemic. Though the chance to resume research may instill a sense of hope, new policies around physical distancing and access to facilities threaten to derail studies—and even careers.
Despite all the uncertainty, the crisis could result in new approaches that ultimately benefit the scientific community and the world. Also this week, Joel Podgorski, a senior scientist in the Water Resources and Drinking Water Department at the Swiss Federal Institute of Aquatic Science and Technology, joins host Sarah Crespi to discuss the global threat of arsenic in drinking water. Arsenic is basically present in all rocks in minute amounts. Under the right conditions it can leach into groundwater and poison drinking water. Without a noticeable taste or smell, arsenic contamination can go undetected for years. The paper, published in Science, estimates that more than 100 million people are at risk of drinking arsenic-contaminated water and provides a guide for the most important places to test.
When New York City’s Poster House museum had to close its doors in early March, director Julia Knight wondered how the institution could support the city.
Today her inspiring solution can be seen across all five boroughs.
Poster House is the first museum in the United States dedicated exclusively to posters.
Through exhibitions, events, and publications, Poster House presents a global view of posters from their earliest appearance in the late 1800s to their present-day use. Poster House takes its mission from the medium, aiming to engage and educate all audiences as we investigate this large-format graphic design and its public impact.
Airlines have strained to survive after travel dried up because of the coronavirus pandemic. WSJ’s Alison Sider explains how airlines are adjusting, and the CEO of Southwest Airlines paints a picture of what the future of flying might look like.
Even limited hearing loss might be associated with cognitive decline. If true, early intervention with hearing aids might help people have better cognitive performance.
Michael Johns III, MD, online editor for JAMA Otolaryngology, speaks with Justin Golub, MD, MS, assistant professor of otolaryngology at Columbia University, whose research has shown that very mild hearing loss can be associated with cognitive disability.
News, Views and Reviews For The Intellectually Curious